Restricted Research - Award List, Note/Discussion Page
Fiscal Year: 2023
1294 University of Houston (143182)
Principal Investigator: Statsyuk,Alexander V
Total Amount of Contract, Award, or Gift (Annual before 2011): $ 235,901
Exceeds $250,000 (Is it flagged?): No
Start and End Dates: 9/1/22 - 8/31/23
Restricted Research: YES
Academic Discipline: Pharmacy
Department, Center, School, or Institute: Pharmacological and Pharmaceutical Sciences
Title of Contract, Award, or Gift: CHEMICAL PLATFORM TO PRODUCE COVALENT BIOLOGICS
Name of Granting or Contracting Agency/Entity:
National Institute of General Medical
CFDA Link: HHS
93.859
Program Title:
n/a
CFDA Linked: Biomedical Research and Research Training
Note:
The objective of the proposed research program is to develop a chemical platform technology to produce and optimize covalent biologics - a new therapeutic modality. Biologic drugs constitute the large sector of drug discovery, however their downside is a high price and the need for frequent injections. SAMs 1.1.1
Discussion: No discussion notes